DOTTER is a globally patented technology-based healthcare company that provides solutions for diagnosing and treating lesions that cause ischemic heart disease.
As a company established by a combination of cardiovascular specialists and the best experts in Korea and the world in the field of optical coherence tomography (OCT), we are designing and producing sophisticated biodegradable stents (BRS) that are 30% thinner than its competitors. In addition, we are mainly developing next-generation OCT equipment, which is optical imaging equipment that can create a synergistic effect for stent insertion.
We aspire to diagnose and cure cardiovascular disease, the leading cause of mortality worldwide, using our unrivaled technological competitiveness, so that humankind can escape the pain of cardiovascular disease and enjoy a longer, healthier life.
Even now, while we pursue continuous technological innovation, we are focusing all our efforts and passion on ensuring the satisfaction of our customers and patients by prioritizing quality and safety.
Subscribe to our media mailing list and get updated with our most recent news
중소벤처기업부가 기업가치 1조원 규모의 유니콘으로 도약할 가능성을 지닌 유망 스타트업 50개사를 선정하고 본격 육성에 나섰다. 중기부는 23일 서울 마포구 스타트업 벤처캠퍼스(SVC 서울)에서 ‘글로벌 유니콘 비전 선포식’을 개최하고, ‘2030년까지 글로벌 유니콘 50개 육성’이라는 비전을 발표했다. 이날 행사에선 올해 신설된 ‘유니콘브릿지’ 사업에
생분해성스텐트(BRS) 임상 환자 128명 모집 완료.
고위험 동맥경화반의 분자적 특성을 밝히는 융합 영상기기 상용화로
110억원 규모 시리즈B 투자 유치 성공.
Headquarter A-911, 323 Incheon Tower-Daero, Yeonsu-Gu, Incheon 22007, Korea
GMP site 1 #1004, 10F, Gasan Digital 1-ro 219, Geumcheon-gu, Seoul 08501, Korea
GMP site 2 A-912, 323 Incheon tower-daero, Yeonsu-gu, Incheon 22007, Korea
Research Lab #315, 23, Doho 1-gil, Samnam-eup, Ulju-gun, Ulsan, Korea
Sales Division #1302, 225, Gasan digital 1-ro, Geumcheon-gu, Seoul, Korea
Phone+82.32.721.6146
our Hours Mon-fri 10:00-18:00 (kST)
info@dotter.com
